PMID- 15083265 OWN - NLM STAT- MEDLINE DCOM- 20041122 LR - 20181113 IS - 0033-3158 (Print) IS - 0033-3158 (Linking) VI - 173 IP - 3-4 DP - 2004 May TI - Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA. PG - 296-309 AB - RATIONALE: Despite the well documented neurochemical actions of 3,4-methylenedioxymethamphetamine (MDMA), acute effects in rats previously exposed to the drug have not been extensively explored. OBJECTIVE: To examine motor activity and vigilance effects of MDMA in drug-naive rats and in rats exposed to the drug 3 weeks earlier. METHODS: MDMA (15 mg/kg, i.p.) was administered to Dark Agouti rats. Motor activity, wakefulness, light slow wave sleep (SWS-1), deep slow wave sleep (SWS-2) and paradoxical sleep (PS), sleep and PS latencies were measured. Acrophases and amplitudes of the 24 h cycles were calculated by cosinor analysis. In parallel groups, local cerebral glucose utilization (lCMRglu) and (3H)-paroxetine binding were measured in motor areas of the brain. RESULTS: In drug-naive rats MDMA caused marked increases in motor activity and wakefulness for at least 5-6 h. Circadian patterns of motor activity and sleep/vigilance parameters were altered up to 5 days after treatment. Despite most parameters tending to return to normal, there were still significant effects of MDMA on motor activity, wakefulness, and SWS-2 28 days later. Acute MDMA administration caused significant increases in lCMRglu, but after 3 weeks lCMRglu was decreased in the same brain areas. No significant change in [3H]paroxetine binding was observed in motor areas, although significant reductions were seen elsewhere (neocortex -81%). In rats exposed to MDMA 3 weeks earlier, most acute effects induced by MDMA administration were similar to those in drug-naive rats, but shorter duration of the acute effects were found in motor activity and vigilance. CONCLUSIONS: Our findings provide evidence that MDMA use can lead to long-term changes in regulation of circadian rhythms, motor activity and sleep generation. FAU - Balogh, Brigitta AU - Balogh B AD - Laboratory of Neurochemistry and Experimental Medicine and Department of Vascular Neurology, Semmelweis University, National Institute of Psychiatry and Neurology, Huvosvolgyi ut 116, 1021 Budapest, Hungary. FAU - Molnar, Eszter AU - Molnar E FAU - Jakus, Rita AU - Jakus R FAU - Quate, Linda AU - Quate L FAU - Olverman, Henry J AU - Olverman HJ FAU - Kelly, Paul A T AU - Kelly PA FAU - Kantor, Sandor AU - Kantor S FAU - Bagdy, Gyorgy AU - Bagdy G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20040409 PL - Germany TA - Psychopharmacology (Berl) JT - Psychopharmacology JID - 7608025 RN - IY9XDZ35W2 (Glucose) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Animals MH - Autoradiography MH - Brain/drug effects/metabolism MH - Circadian Rhythm/*drug effects MH - Glucose/metabolism MH - Male MH - Motor Activity/*drug effects MH - N-Methyl-3,4-methylenedioxyamphetamine/administration & dosage/*pharmacology MH - Radioligand Assay MH - Rats MH - Sleep/*drug effects MH - Wakefulness/drug effects EDAT- 2004/04/15 05:00 MHDA- 2004/12/16 09:00 CRDT- 2004/04/15 05:00 PHST- 2003/09/30 00:00 [received] PHST- 2003/12/21 00:00 [accepted] PHST- 2004/04/15 05:00 [pubmed] PHST- 2004/12/16 09:00 [medline] PHST- 2004/04/15 05:00 [entrez] AID - 10.1007/s00213-004-1787-9 [doi] PST - ppublish SO - Psychopharmacology (Berl). 2004 May;173(3-4):296-309. doi: 10.1007/s00213-004-1787-9. Epub 2004 Apr 9.